• According to Transparency Market Research’s latest report on the global digital pathology market for the historical period 2017–2018 and forecast period 2019–2027, rising awareness about digital pathology and increase in demand for advanced technology are the factors likely to boost the growth of digital pathology market. Moreover, high incidence and prevalence of cancer and other chronic diseases is poised to escalate the growth of digital pathology market.
  • According to the report, the global digital pathology market was valued at US$ 0.38 Bn in 2018 and is anticipated to expand at a CAGR of over 12.0% from 2019 to 2027
fa global digital pathology market

To know the scope of our report Get a Sample on Digital Pathology Market?

Rise in Focus on Research & Development and Increase in Prevalence of Cancer: Key Drivers of Global Digital Pathology Market

  • Cancer is emerging as crucial public health problem worldwide and it is unconquered. World Health Organization states that, in 2018, estimated 9.6 million deaths and 18.1 million new cases of cancer were recorded globally
  • There is an increase in the number of cancer cases due to growing elderly population globally coupled with unhealthy lifestyles. According to Cancer Facts & Figures 2019, estimated number of older adults, aged 85 years and above was 6.4 million in 2016 and it is expected to reach 19.0 million by 2060. In 2019, 1,944,280 adults aged 85 and older were alive with a history of cancer
  • Breast, lung and prostate cancers are the most frequently diagnosed types of cancer in industrialized countries such as the U.S., U.K. and Japan. Hence, increasing incidences of cancer accentuates the uptake of digital pathology systems market during the study period. This in turn is projected to boost the growth of global digital pathology market.
  • Preclinical studies using animal model and clinical trials play an important role assessing the safety and efficacy of the drugs. Digital pathology aids in minimizing the error rate, storage of the drug data, also the integration of the data in electronic health records (EHRs), and evaluation of the patient’s response to a particular drug etc.
  • Rising focus on research and development for drug development and drug discoveries is leading to surge in number of clinical and preclinical trials which is augmenting the growth of global digital pathology market. Furthermore, rise in number of research conducted in academics and research institutes is likely to augment the growth of market.

Get a glimpse of the in-depth analysis through our Report Brochure

Technological Advancements Propel Global Digital Pathology Market Growth

  • Manual interpretation of tissue slides for disease diagnosis purpose is costly and labor extensive that increases error and inconsistency in the diagnostic result and it increases the risk of diagnostic failure and impedes decision making process.
  • Technological advancements in digital pathology helps to overcome limitation as these systems provide efficient and effective results of diagnostic tests.
  • Moreover, digital pathology systems can analyze large array of slides within short duration without any diagnostic error. These factors collectively account for the global market demand of digital pathology systems during the forecast period

Expanding operations in future? To get the perfect launch ask for a custom report 

High Cost of the System to Hamper Global Digital Pathology Market

  • High cost associated with technologically advanced digital pathology system is expected to restrain the growth of digital pathology market. For instance, the average cost of the digital pathology systems for telepathology and whole slide imaging is between US$ 30 000 and US$ 300 000, which can be unaffordable for many low resource environment in developing countries
  • In addition to the cost, the digital pathology systems require costly infrastructure such as larger memory to store data, thereby restricting the usage of digital pathology system this is leading to restraining the growth of global digital pathology market

Stringent Regulations to Restrain Global Digital Pathology Market

  • Slide scanners and whole slide imaging devices are involved in the digital pathology systems for diagnostic purpose and these devices require the regulatory approval before commercialization.
  • In addition, in the U.S. market, clinical laboratories have to meet the criteria and standards of Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologist (CAP) pertaining to the utilization of digital pathology.
  • Few CLIA regulations are required to be considered for implementing a digital pathology system for diagnosis purpose such as Section 493.1251 (procedure manual), Section 493.1252 (test systems, equipment, instruments) and Section 493.1253 (establishment and verification of performance).
  • Such regulations imposed by agencies such as FDA, CLIA and CAP on digital pathology systems, manufacturers experience a tough phase throughout the approval process and commercialization of their products, which restrains the growth of the global digital pathology market

Global Digital Pathology Market: Competitive Landscape

  • This report profiles major players in the global digital pathology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global digital pathology market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global digital pathology market are
    • Leica Biosystems Imaging, Inc
    • OLYMPUS CORPORATION
    • F. Hoffmann-La Roche Ltd
    • Mikroscan Technologies, Inc.
    • Koninklijke Philips N.V.
    •  Sectra AB and Inspirata 

Global Digital Pathology Market: Key Developments

Key players in the global digital pathology market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global digital pathology market. A few expansion strategies adopted by players operating in the global digital pathology market are:

  • In February 2019, Neuberg Diagnostics and OptraSCAN Inc. announced the launch of Global TELEPath Network for the pathologist community in UAE, India and South Africa under a new joint venture namely Neuberg DIGIPATH. This is enabled to increase focus on providing advanced and affordable digital pathology solutions
  • In March 2018, F. Hoffmann-La Roche Ltd announced the launch of VENTANA DP 200 slide scanner for digital pathology. The slide scanner is high speed and produces images with high image quality. The launch of the product will broaden the product portfolio of the company and strengthen its position in digital pathology market.
  • In January 2018, Inspirata announced that it has acquired the company Omnyx from GE healthcare. The acquisition of the company will ensure that Inspirata has the one of the most comprehensive digital pathology solution work flow

The report on the global digital pathology market discussed individual strategies, followed by company profiles of manufacturers of digital pathology. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global digital pathology market

TMR’s report on the global digital pathology market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global digital pathology market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global digital pathology market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global digital pathology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global digital pathology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global digital pathology market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global digital pathology market.

The report delves into the competitive landscape of the global digital pathology market. Key players operating in the global digital pathology market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global digital pathology market that have been profiled in this report.

Key Questions Answered in Global Digital Pathology Market Report

  • What is the scope of growth for product companies in the global digital pathology market?
  • What will be the Y-o-Y growth of the global digital pathology market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global digital pathology market?
  • Will North America continue to be the most profitable market for digital pathology providers?
  • Which factors are anticipated to hamper the growth of the global digital pathology market during the forecast period?
  • Which are the leading companies in the global digital pathology market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global digital pathology market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global digital pathology market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the digital pathology market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the digital pathology market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global digital pathology market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global digital pathology more reliably and accurately.

Regional Segmentation of Digital Pathology Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Global Digital Pathology Market - Segmentation

Product Type

Image Analysis Software

Scanner

Applications

Diagnosis

Consulting Services

Educational

Others

End-user

Diagnostic Laboratories

Academic & Research Centers

Pharmaceutical Companies

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Digital Pathology Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type/Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Digital Pathology Market Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Healthcare IT Spending 

    5.2. Digital Pathology Market Overview

    5.3. Epidemiology of Cancer by Country/Sub-region

6. Global Digital Pathology Market Analysis and Forecasts, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Digital Pathology Market Value Forecast by Product Type, 2017–2027

        6.3.1. Image Analysis Software

        6.3.2. Scanner

    6.4. Global Digital Pathology Market Attractiveness by Product Type

7. Global Digital Pathology Market Analysis and Forecasts, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Digital Pathology Market Value Forecast by End-user, 2017–2027

        7.3.1. Diagnostic Laboratories

        7.3.2. Academic & Research Centers

        7.3.3. Pharmaceutical Companies

        7.3.4. Others

    7.4. Global Digital Pathology Market Attractiveness by End-user

8. Global Digital Pathology Market Analysis and Forecasts, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Digital Pathology Market Value Forecast by Application, 2017–2027

        8.3.1. Diagnosis

        8.3.2. Consulting Services

        8.3.3. Educational

        8.3.4. Others

    8.4. Global Digital Pathology Market Attractiveness by End-user

9. Global Digital Pathology Market Analysis and Forecasts, by Region

    9.1. Key Findings

    9.2. Global Digital Pathology Market Value Forecast by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Digital Pathology Market Attractiveness by Country/Region

10. North America Digital Pathology Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Digital Pathology Market Value Forecast by Product Type, 2017–2027

        10.2.1. Image Analysis Software

        10.2.2. Scanner

    10.3. North America Digital Pathology Market Value Forecast by End-user, 2017–2027

        10.3.1. Diagnostic Laboratories

        10.3.2. Academic & Research Centers

        10.3.3. Pharmaceutical Companies

        10.3.4. Others

    10.4. North America Digital Pathology Market Value Forecast by Application, 2017–2027

        10.4.1. Diagnosis

        10.4.2. Consulting Services

        10.4.3. Educational

        10.4.4. Others

    10.5. North America Digital Pathology Market Value Forecast by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Digital Pathology Market Attractiveness Analysis 

        10.6.1. By Product Type

        10.6.2. By End-user

        10.6.3. By Application

        10.6.4. By Country

11. Europe Digital Pathology Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Digital Pathology Market Value Forecast by Product Type, 2017–2027

        11.2.1. Image Analysis Software

        11.2.2. Scanner

    11.3. Europe Digital Pathology Market Value Forecast by End-user, 2017–2027

        11.3.1. Diagnostic Laboratories

        11.3.2. Academic & Research Centers

        11.3.3. Pharmaceutical Companies

        11.3.4. Others

    11.4. Europe Digital Pathology Market Value Forecast by Application, 2017–2027

        11.4.1. Diagnosis

        11.4.2. Consulting Services

        11.4.3. Educational

        11.4.4. Others

    11.5. Europe Digital Pathology Market Value Forecast by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Digital Pathology Market Attractiveness Analysis 

        11.6.1. By Product Type

        11.6.2. By End-user

        11.6.3. By Application

        11.6.4. By Country/Sub-region

12. Asia Pacific Digital Pathology Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Digital Pathology Market Value Forecast by Product Type, 2017–2027

        12.2.1. Image Analysis Software

        12.2.2. Scanner

    12.3. Asia Pacific Digital Pathology Market Value Forecast by End-user, 2017–2027

        12.3.1. Diagnostic Laboratories

        12.3.2. Academic & Research Centers

        12.3.3. Pharmaceutical Companies

        12.3.4. Others

    12.4. Asia Pacific Digital Pathology Market Value Forecast by Application, 2017–2027

        12.4.1. Diagnosis

        12.4.2. Consulting Services

        12.4.3. Educational

        12.4.4. Others

    12.5. Asia Pacific Digital Pathology Market Value Forecast by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Digital Pathology Market Attractiveness Analysis 

        12.6.1. By Product Type

        12.6.2. By End-user

        12.6.3. By Application

        12.6.4. By Country/Sub-region

13. Latin America Digital Pathology Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Digital Pathology Market Value Forecast by Product Type, 2017–2027

        13.2.1. Image Analysis Software

        13.2.2. Scanner

    13.3. Latin America Digital Pathology Market Value Forecast by End-user, 2017–2027

        13.3.1. Diagnostic Laboratories

        13.3.2. Academic & Research Centers

        13.3.3. Pharmaceutical Companies

        13.3.4. Others

    13.4. Latin America Digital Pathology Market Value Forecast by Application, 2017–2027

        13.4.1. Diagnosis

        13.4.2. Consulting Services

        13.4.3. Educational

        13.4.4. Others

    13.5. Latin America Digital Pathology Market Value Forecast by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Digital Pathology Market Attractiveness Analysis 

        13.6.1. By Product Type

        13.6.2. By End-user

        13.6.3. By Application

        13.6.4. By Country/Sub-region

14. Middle East & Africa Digital Pathology Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Digital Pathology Market Value Forecast by Product Type, 2017–2027

        14.2.1. Image Analysis Software

        14.2.2. Scanner

    14.3. Middle East & Africa Digital Pathology Market Value Forecast by End-user, 2017–2027

        14.3.1. Diagnostic Laboratories

        14.3.2. Academic & Research Centers

        14.3.3. Pharmaceutical Companies

        14.3.4. Others

    14.4. Middle East & Africa Digital Pathology Market Value Forecast by Application, 2017– 2027

        14.4.1. Diagnosis

        14.4.2. Consulting Services

        14.4.3. Educational

        14.4.4. Others

    14.5. Middle East & Africa Digital Pathology Market Value Forecast by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Digital Pathology Market Attractiveness Analysis 

        14.6.1. By Product Type

        14.6.2. By End-user

        14.6.3. By Application

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking By Company (2018)

    15.3. Company Profiles

        15.3.1. Leica Biosystems Imaging, Inc

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis. 

        15.3.2. OLYMPUS CORPORATION

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis. 

        15.3.3. F. Hoffmann-La Roche Ltd

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis. 

        15.3.4. Mikroscan Technologies, Inc.

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis. 

        15.3.5. Koninklijke Philips N.V.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis. 

        15.3.6. Sectra AB

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis. 

        15.3.7. Inspirata 

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis. 

List of Table

Table 01: Global Digital Pathology Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 02: Global Digital Pathology Market Size (US$ Mn) Forecast, by End Users, 2017–2027

Table 03: Global Digital Pathology Market Size (US$ Mn) Forecast, by Applications, 2017–2027

Table 04: Global Digital Pathology Market Size Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Digital Pathology Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 06: North America Digital Pathology Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07: North America Digital Pathology Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08: North America Digital Pathology Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: Europe Digital Pathology Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 10: Europe Digital Pathology Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 11: Europe Digital Pathology Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 12: Europe Digital Pathology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Asia Pacific Digital Pathology Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 14: Asia Pacific Digital Pathology Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Asia Pacific Digital Pathology Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 16: Asia Pacific Digital Pathology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Latin America Digital Pathology Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 18: Latin America Digital Pathology Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Latin America Digital Pathology Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 20: Latin America Digital Pathology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Middle East & Africa Digital Pathology Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 22: Middle East & Africa Digital Pathology Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 23: Middle East & Africa Digital Pathology Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 24: Middle East & Africa Digital Pathology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figure

Figure 01: Global Digital Pathology Market Revenue, By Product (US$ Mn), 2018

Figure 02: Global Digital Pathology Market Revenue, By End Users (US$ Mn), 2018

Figure 03: Global Digital Pathology Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 04: Global Digital Pathology Market, Key Industry Developments

Figure 05: Global Digital Pathology Market Size, By Value (US$ Mn) Analysis and Forecast, 2017–2027

Figure 06: Digital Pathology Market Value Share, by Product Type (2018)

Figure 07: Digital Pathology Market Value Share, by End Users (2018)

Figure 08: Digital Pathology Market Value Share, by Applications (2018)

Figure 09: Global Digital Pathology Market Value Share Analysis, by Product, 2018 and 2027

Figure 10: Global Digital Pathology Market Revenue by Image Analysis Software (US$ Mn), 2017–2027

Figure 11: Global Digital Pathology Market Revenue by Scanners (US$ Mn), 2017–2027

Figure 12: Global Digital Pathology Market Attractiveness Analysis, by Product Type, 2019-2027

Figure 13: Global Digital Pathology Market Value Share Analysis, by End Users, 2018 and 2027

Figure 14: Global Digital Pathology Market Revenue by Diagnostic Laboratories (US$ Mn), 2017–2027

Figure 15: Global Digital Pathology Market Revenue by Academic & Research Centers (US$ Mn), 2017–2027

Figure 16: Global Digital Pathology Market Revenue by Pharmaceutical Companies (US$ Mn), 2017–2027

Figure 17: Global digital Pathology Market Revenue by (US$ Mn), 2017–2027

Figure 18: Global Digital Pathology Market Attractiveness Analysis, by End Users, 2019-2027

Figure 19: Global Safety Market Value Share Analysis, by Applications, 2018 and 2027

Figure 20: Global Digital Pathology Market Revenue by Diagnosis (US$ Mn), 2017–2027

Figure 21: Global Digital Pathology Market Revenue by Consulting Services (US$ Mn), 2017–2027

Figure 22: Global Digital Pathology Market Revenue by Educational (US$ Mn), 2017–2027

Figure 23: Global digital Pathology Market Revenue by (US$ Mn), 2017–2027

Figure 24: Global Digital Pathology Market Attractiveness Analysis, by Applications, 2019-2027

Figure 25: Global Digital Pathology Market Value Share Analysis, by Region, 2018 and 2027

Figure 26: Global Digital Pathology Market Attractiveness Analysis, by Region

Figure 27: North America Digital Pathology Market Value (US$ Mn) Forecast, 2017–2027

Figure 28: North Digital Pathology Market Attractiveness, by Country, 2019–2027

Figure 29: North America Digital Pathology Market Value Share Analysis, by Product, 2018 and 2027

Figure 30: North America Digital Pathology Market Value Share Analysis, by End-user, 2018 and 2027

Figure 31: North America Digital Pathology Market Value Share Analysis, by Application, 2018 and 2027

Figure 32: North America Digital Pathology Market Value Share Analysis, by Country, 2018 and 2027

Figure 33: North America Digital Pathology Market Attractiveness Analysis, by Product

Figure 34: North America Digital Pathology Market Attractiveness Analysis, by End-user

Figure 35: North America Digital Pathology Market Attractiveness Analysis, by Application

Figure 36: Europe Digital Pathology Market Value (US$ Mn) Forecast, 2017–2027

Figure 37: North Digital Pathology Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 38: Europe Digital Pathology Market Value Share, by Product, 2018 and 2027

Figure 39: Europe Digital Pathology Market Value Share, by End-user, 2018 and 2027

Figure 40: Europe Digital Pathology Market Value Share, by Application, 2018 and 2027

Figure 41: Europe Digital Pathology Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 42: Europe Digital Pathology Market Attractiveness, by Product

Figure 43: Europe Digital Pathology Market Attractiveness, by End-user

Figure 44: Europe Digital Pathology Market Attractiveness, by Application

Figure 45: Asia Pacific Digital Pathology Market Value (US$ Mn) Forecast, 2017–2027

Figure 46: Asia Pacific Digital Pathology Market Attractiveness, by Country/Sub Region, 2019–2027

Figure 47: Asia Pacific Digital Pathology Market Value Share Analysis, by Product, 2018 and 2027

Figure 48: Asia Pacific Digital Pathology Market Value Share Analysis, by End-user, 2018 and 2027

Figure 49: Asia Pacific Digital Pathology Market Value Share Analysis, by Application, 2018 and 2027

Figure 50: Asia Pacific Digital Pathology Market Value Share Analysis, by Country, 2018 and 2027

Figure 51: Asia Pacific Digital Pathology Market Attractiveness Analysis, by Product Type

Figure 52: Asia Pacific Digital Pathology Market Attractiveness Analysis, by End-user

Figure 53: Asia Pacific Digital Pathology Market Attractiveness Analysis, by Application

Figure 54: Latin America Digital Pathology Market Value (US$ Mn) Forecast, 2017–2027

Figure 55: Latin America Digital Pathology Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 56: Latin America Digital Pathology Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 57: Latin America Digital Pathology Market Value Share Analysis, by End-user, 2018 and 2027

Figure 58: Latin America Digital Pathology Market Value Share Analysis, by Application, 2018 and 2027

Figure 59: Latin America Digital Pathology Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 60: Latin America Digital Pathology Market Attractiveness Analysis, by Product Type

Figure 61: Latin America Digital Pathology Market Attractiveness Analysis, by End-user

Figure 62: Latin America Digital Pathology Market Attractiveness Analysis, by Application

Figure 63: Middle East & Africa Digital Pathology Market Value (US$ Mn) Forecast, 2017–2027

Figure 64: Middle East & Africa Digital Pathology Market Attractiveness, by Country/Sub Region, 2019–2027

Figure 65: Middle East & Africa Digital Pathology Market Value Share Analysis, by Product, 2018 and 2027

Figure 66: Middle East & Africa Digital Pathology Market Value Share Analysis, by End-user, 2018 and 2027

Figure 67: Middle East & Africa Digital Pathology Market Value Share Analysis, by Application, 2018 and 2027

Figure 68: Middle East & Africa Digital Pathology Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 69: Middle East & Africa Digital Pathology Market Attractiveness Analysis, by Product Type

Figure 70: Middle East & Africa Digital Pathology Market Attractiveness Analysis, by End-user

Figure 71: Middle East & Africa Digital Pathology Market Attractiveness Analysis, by Application

Figure 72: Global Digital Pathology Market Share Analysis By Company (2018)

Figure 73: Danaher (Diagnostics) Revenue (US$ Mn) and Y-o-Y Growth (%)

Figure 74: Danaher (Diagnostics) Breakdown of Net Sales, by Business Sub-Segment

Figure 75: Danaher (Diagnostics) Breakdown of Net Sales, by Region

Figure 76: Danaher (Diagnostics) R & D Expenditures, 

Figure 77: Olympus Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%)

Figure 78: Olympus Corporation, Breakdown of Net Sales, by Business Sub-Segment

Figure 79: Geratherm Medical AG, Breakdown of Net Sales, by Region

Figure 80: F. Hoffmann-La Roche Ltd Revenue (US$ Mn) & Y-o-Y Growth (%)

Figure 81: F. Hoffmann-La Roche Ltd Global Diabetes Care Revenue (US$ Mn) & Y-o-Y Growth (%)

Figure 82 F. Hoffmann-La Roche Ltd Breakdown of Net Sales, by Business Segments

Figure 83: F. Hoffmann-La Roche Ltd Breakdown of Diagnostics Division Sales, by Segments

Figure 84: Koninklijke Philips N.V. Revenue (US$ Mn) & Y-o-Y Growth (%)

Figure 85:  Koninklijke Philips N.V. Research & Development Expenses

Figure 86: Koninklijke Philips N.V. Breakdown of Net Sales, by Segment 

Figure 87: Koninklijke Philips N.V. Breakdown of Net Sales, by Region

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Digital Pathology Systems